Applied DNA Sciences Inc (APDN) — Capital Reinvestment Ratio

Latest as of March 2023: 0.25x

Applied DNA Sciences Inc (APDN) has a Capital Reinvestment Ratio of 0.25x as of March 2023, meaning it reinvests 0% of its operating cash flow ($214.39K) in capital expenditures ($54.34K). See APDN equity financing ratio to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.25x

Capex / Operating Cash Flow

Operating Cash Flow

$214.39K

USD

Capital Expenditures

$54.34K

USD

Data as of

Mar 2023

Most recent filing

Annual Capital Reinvestment Ratio for Applied DNA Sciences Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Applied DNA Sciences Inc from None to None. For live market cap and broader valuation context, see Applied DNA Sciences Inc market capitalisation.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow